Assessment of dietary therapies in a canine model of Batten disease

European Journal of Paediatric Neurology

Volumn 5, Issue SUPPL. A, 2001, Pages 151-156

  Siakotos, A N ^a   Hutchins, G D ^a   Farlow, M R ^a   Katz, M L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain atrophy; Carnitine; Ceroid lipofuscinosis; Cognitive decline; Dietary supplementation; Dogs; Fish oil

Indexed keywords

CARNITINE; CORN OIL; FISH OIL; GLUCOSE; POLYUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE COURSE; DOG; GLUCOSE METABOLISM; HUMAN; INHERITANCE; LABORATORY; LIFESPAN; MEDICAL ASSESSMENT; MONITORING; NEURONAL CEROID LIPOFUSCINOSIS; NON INVASIVE MEASUREMENT; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROGNOSIS; SPECIES; STAGING; UNITED KINGDOM;

EID: 0034923782     PISSN: 10903798     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejpn.2000.0453     Document Type: Article

References (27)

1. Batten's disease: Eight genes and still counting?
2. Comparative biology of the neuronal ceroid lipofuscinoses (NCL): An overview
3. The English Setter with ceroid-lipofuscinosis: A suitable model for the juvenile type of ceroid lipofuscinosis in humans
4. Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English Setter dogs
5. Animal models for the ceroid lipofuscinoses
6. Juvenile neuronal ceroid lipofuscinosis: Developmental progress after supplementation with polyunsaturated fatty acids
7. Dietary carnitine supplements slow disease progression in a putative mouse model for hereditary ceroid lipofuscinosis
8. The presence of oxidative polymeric materials in encapsulated fish oils
9. The value of positron emission tomography in the diagnosis and monitoring of late infantile and juvenile lipopigment storage disorders (so-called Batten or neuronal ceroid lipofuscinoses)
10. Microdetermination of (-) carnitine and carnitine acetyltransferase
11. Seizures, depression and dementia in teenagers with Batten disease
12. Carnitine metabolism and functions
13. Mitochondrial metabolism of 12- and 12-hydroxyeicosatetraenoic acids
14. Carnitine-acetyl translocase deficiency: Implications in human pathology
15. Role of acetyl-L-carnitine in rat brain lipogenesis: Implications for polyunsaturated fatty acid biosynthesis
16. Secondary carnitine deficiency and impaired docosahexaenoic acid synthesis; a common denominator in the pathophysiology of diseases of oxidative phosphorylation and b-oxidation
17. Low erythrocyte plasmalogen and plasma docosahexaenoic acid (DHA) in juvenile neuronal ceroid-lipofuscinosis
18. L-Carnitine administration and withdrawal affect plasma and hepatic carnitine concentrations, plasma lipid and lipoprotein composition, and in vitro hepatic lipogenesis from labeled mevalonate and oleate in normal rabbits
19. Effect of carnitine supplementation in lipid parameters in hemodialysis patients
20. Prenatal effects of beta methasone-L-carnitine combinations on fetal rat lung
21. Effect of L-carnitine on plasma lipoprotein fatty acids pattern in patients with primary hyperliproteinemia
22. 11c-carnitine in muscle of a myopathic carnitine-deficient patient using positron emission scintigraphy
23. Decreased erythrocyte and platelet phospholipids and fatty acids in juvenile ceroid lipofuscinosis
24. Therapeutic modification of membrane lipid abnormalities in juvenile ceroid lipofuscinosis (Batten disease)
25. Experimental studies on antiarrhythmic and antiseizure effects of polyunsaturated fatty acids in excitable tissues
26. Dietary supplementation with n-3 polyunsaturated fatty acid and vitamin E after myocardial infarction: Results of the GISSI-Prevensione trial
27. Long-term acetyl-L-carnitine treatment in Alzheimer's disease